• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The qualification and disqualification of patients and events in long-term cardiovascular clinical trials.

作者信息

Gent M, Sackett D L

出版信息

Thromb Haemost. 1979 Feb 28;41(1):123-34.

PMID:384581
Abstract
摘要

相似文献

1
The qualification and disqualification of patients and events in long-term cardiovascular clinical trials.
Thromb Haemost. 1979 Feb 28;41(1):123-34.
2
Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone.罕见事件的荟萃分析：罗格列酮随机试验中心血管事件的更新与敏感性分析
Clin Trials. 2008;5(2):116-20. doi: 10.1177/1740774508090212.
3
[Identification of patients with acute myocardial infarction that may be discharged early: prospective evaluation with simple clinical and instrumental indicators].[急性心肌梗死患者早期出院可能性的识别：采用简单临床和仪器指标的前瞻性评估]
Ital Heart J Suppl. 2001 Jul;2(7):775-82.
4
Clinical trials of platelet-active drugs in coronary heart disease: summary of design features.
Circulation. 1980 Dec;62(6 Pt 2):V49-52.
5
Prognosis of patients with atherothrombotic disease: a prospective survey in a non-hospital setting.动脉粥样硬化血栓形成性疾病患者的预后：非医院环境下的前瞻性调查。
Int J Cardiol. 2006 Oct 10;112(3):302-7. doi: 10.1016/j.ijcard.2005.09.024. Epub 2005 Dec 1.
6
Baroreflex sensitivity predicts long-term cardiovascular mortality after myocardial infarction even in patients with preserved left ventricular function.压力反射敏感性可预测心肌梗死后的长期心血管死亡率，即使是左心室功能保留的患者。
J Am Coll Cardiol. 2007 Dec 11;50(24):2285-90. doi: 10.1016/j.jacc.2007.08.043. Epub 2007 Nov 26.
7
[Effect of cardiovascular risk factors on long-term morbidity and mortality following acute myocardial infarction].
Rev Esp Cardiol. 2007 Jul;60(7):703-13.
8
Modalities of treatment and 30-day outcomes of unselected patients older than 75 years with acute ST-elevation myocardial infarction: data from the BLITZ study.75岁以上非选择性急性ST段抬高型心肌梗死患者的治疗方式及30天预后：来自BLITZ研究的数据
J Cardiovasc Med (Hagerstown). 2008 Oct;9(10):1045-51. doi: 10.2459/JCM.0b013e32830eb6eb.
9
Sex differences in perceived risks, distrust, and willingness to participate in clinical trials: a randomized study of cardiovascular prevention trials.在感知风险、不信任以及参与临床试验的意愿方面的性别差异：一项心血管预防试验的随机研究。
Arch Intern Med. 2007 May 14;167(9):905-12. doi: 10.1001/archinte.167.9.905.
10
Beneficial impact of Xuezhikang on cardiovascular events and mortality in elderly hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS).血脂康对中国冠心病二级预防研究（CCSPS）中既往有心肌梗死病史的老年高血压患者心血管事件及死亡率的有益影响。
J Clin Pharmacol. 2009 Aug;49(8):947-56. doi: 10.1177/0091270009337509.

引用本文的文献

1
Association of Periodic Limb Movements and Obstructive Sleep Apnea With Risk of Cardiovascular Disease and Mortality.周期性肢体运动和阻塞性睡眠呼吸暂停与心血管疾病风险及死亡率的关联。
J Am Heart Assoc. 2024 Feb 6;13(3):e031630. doi: 10.1161/JAHA.123.031630. Epub 2024 Jan 19.
2
The Determining Risk of Vascular Events by Apnea Monitoring (DREAM) study: design, rationale, and methods.通过呼吸暂停监测确定血管事件风险（DREAM）研究：设计、原理及方法
Sleep Breath. 2016 May;20(2):893-900. doi: 10.1007/s11325-015-1254-3. Epub 2015 Dec 7.
3
Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis.
随机分组后的排除标准：意向性分析原则及将患者排除在分析之外。
BMJ. 2002 Sep 21;325(7365):652-4. doi: 10.1136/bmj.325.7365.652.
4
Does delirium contribute to poor hospital outcomes? A three-site epidemiologic study.谵妄是否会导致不良的医院治疗结果？一项三中心流行病学研究。
J Gen Intern Med. 1998 Apr;13(4):234-42. doi: 10.1046/j.1525-1497.1998.00073.x.
5
A predictive index for functional decline in hospitalized elderly medical patients.住院老年内科患者功能衰退的预测指标。
J Gen Intern Med. 1993 Dec;8(12):645-52. doi: 10.1007/BF02598279.
6
Eight-year follow-up of adjuvant therapy for stage II breast cancer.
World J Surg. 1985 Oct;9(5):738-49. doi: 10.1007/BF01655189.